Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Don't forget about IOV in Banff in November

<< Previous

Bullboard Posts

Next >>

Post by askretkaon Oct 01, 2023 11:14pm

311 Views

Post# 35664415

Don't forget about IOV in Banff in November

Good summary Canadafan.

Although not as big a catalyst. I would add IOV conference in Banff as well. It was mentioned in fireside chat as well. Agenda is up. Couple interesting things in there including a talk about our Breast Cancer by Dr Heineman
And CAR-T and Virus talk by one of researchers who worked with Dr. Vile on original mouse study.

https://cumming.ucalgary.ca/research/immune-oncology-initiative/iovc-2023/scientific-agenda

Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

<< Previous

Bullboard Posts

Next >>

Grand Portage Resources pioneers new gold exploration in Alaska